| UBS (LUX) EMERGING MARKET CORPORATE INVESTMENT GRADE BOND Q-ACC | DEUDA PRIVADA EMERGENTES HRD CCY | 5,92% | · | · | · |
| UBS (LUX) EQUITY FUND - BIOTECH (USD) (EUR) Q-ACC | RVI BIOTECNOLOGÍA | 55,16% | 47,90% | · | · |
| UBS (LUX) EQUITY FUND - GLOBAL SUSTAINABLE (USD) (CHF PORTFOLIO HEDGED) F-ACC | RVI GLOBAL | 15,46% | 43,22% | · | · |
| UBS (LUX) EQUITY FUND - GLOBAL SUSTAINABLE (USD) (EUR) P-ACC | RVI GLOBAL | 20,77% | · | · | · |
| UBS (LUX) EQUITY FUND - GLOBAL SUSTAINABLE (USD) (EUR PORTFOLIO HEDGED) F-ACC | RVI GLOBAL | 17,87% | 47,83% | · | · |
| UBS (LUX) EQUITY FUND - GLOBAL SUSTAINABLE (USD) (GBP PORTFOLIO HEDGED) F-ACC | RVI GLOBAL | 21,84% | 56,80% | · | · |
| UBS (LUX) EQUITY FUND - GLOBAL SUSTAINABLE (USD) (USD PORTFOLIO HEDGED) F-ACC | RVI GLOBAL | 23,99% | 53,08% | · | · |
| UBS (LUX) EQUITY FUND - SUSTAINABLE HEALTH TRANSFORMATION (USD) (CHF HEDGED) P-ACC | RVI SALUD | 16,56% | 15,17% | · | · |
| UBS (LUX) EQUITY FUND - SUSTAINABLE HEALTH TRANSFORMATION (USD) (CHF HEDGED) Q-ACC | RVI SALUD | 17,50% | 17,97% | · | · |
| UBS (LUX) EQUITY FUND - SUSTAINABLE HEALTH TRANSFORMATION (USD) (EUR HEDGED) P-ACC | RVI SALUD | 19,18% | 19,23% | · | · |
